IGF2 and hepatocellular carcinoma: This combination was performed using multivariate discriminate analysis (MDA) for predicting HCC patients as follows; MDA model = 1.17 + AFP (U/L) × 0.002 + IGF2 (pg/ml) × 0.001 + IL6 (pg/ml) × 0.008 – platelet count (× 109/L) × 0.001).